BSPM
Biostar Pharmaceuticals, Inc.
BSPM
BSPM
Delisted
BSPM was delisted on the 18th of September, 2018.
7 hedge funds and large institutions have $189K invested in Biostar Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 0 closing their positions.
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Acadian Asset Management
Boston,
Massachusetts
|
$18K |
| 2 |
2
Barclays
London,
United Kingdom
|
$2K |
Top Sellers
| 1 |
AIM
1
Acrospire Investment Management
Chicago,
Illinois
|
$27K |
| 2 |
2
JPMorgan Chase & Co
New York
|
$68K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$2K |
| 4 |
4
Morgan Stanley
New York
|
$72K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $72K | 31,174 | -224 | -0.7% |
|
|
2
JPMorgan Chase & Co
New York
| $68K | 29,282 | -13,195 | -31% |
|
|
AIM
3
Acrospire Investment Management
Chicago,
Illinois
| $27K | 11,740 | -20,279 | -63% |
|
|
4
Acadian Asset Management
Boston,
Massachusetts
| $18K | 7,916 | +3,719 | +89% |
|
|
5
UBS Group
Zurich,
Switzerland
| $2K | 1,000 | -1,424 | -59% |
|
|
6
Barclays
London,
United Kingdom
| $2K | 1,000 | +530 | +113% |
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $0 | 401 | +400 | +40,000% |
|